Gitte Aabo - GN Store Chief Hearing
| GGNDF Stock | USD 19.40 0.00 0.00% |
Executive
Ms. Gitte Pugholm Aabo was Independent Director at GN STORE NORD AS since March 13, 2018. She holds MBA, HD graduate diploma in business administration, Bachelor of economy. She is CEO, LEO Pharma AS. She also serves as Member of the Committee of Directors of Danmarks Nationalbank, the American Skin Association Board, the American Skin Association Education Council, the European Federation of Pharmaceutical Industries and Associations. She has leadership experience from the pharma industry and special knowledge within international management, finance previously as CFO of LEO Pharma IT, sales and marketing in the medical sector as well as deep insights into building digital communities. since 2018.
| Age | 56 |
| Tenure | 7 years |
| Professional Marks | MBA |
| Phone | 45 45 75 00 00 |
| Web | https://www.gn.com |
GN Store Management Efficiency
The company has return on total asset (ROA) of 0.0376 % which means that it generated a profit of $0.0376 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0875 %, meaning that it generated $0.0875 on every $100 dollars invested by stockholders. GN Store's management efficiency ratios could be used to measure how well GN Store manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Bill Keyes | icad inc | N/A | |
| Eric Lonnqvist | icad inc | N/A | |
| Niels Wagner | Demant AS ADR | 52 | |
| John Ferrell | CONMED | 56 | |
| Vasu Avadhanula | icad inc | N/A | |
| Darleen Caron | Siemens Healthineers AG | 59 | |
| Annette Heroux | icad inc | 68 | |
| Deina CPA | Bone Biologics Corp | 61 | |
| Hollie Foust | CONMED | N/A | |
| David Hackshall | CochLear Ltd ADR | N/A | |
| Brent Lalomia | CONMED | 49 | |
| Sarah Oliker | CONMED | 43 | |
| Jan Metzdorff | Sonova Holding AG | 60 | |
| Daniel Esq | CONMED | 60 | |
| Peter Graham | icad inc | N/A | |
| Kimberly Lockwood | CONMED | N/A | |
| Michelle Strong | icad inc | N/A | |
| Richard Glaze | CONMED | 59 | |
| Deina Walsh | Bone Biologics Corp | 60 | |
Management Performance
| Return On Equity | 0.0875 | |||
| Return On Asset | 0.0376 |
GN Store Nord Leadership Team
Elected by the shareholders, the GN Store's board of directors comprises two types of representatives: GN Store inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GGNDF. The board's role is to monitor GN Store's management team and ensure that shareholders' interests are well served. GN Store's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GN Store's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anne Veyhe, Treasury Relations | ||
| Peter Gormsen, Chief Officer | ||
| Rene SvendsenTune, Member of the Executive Management Team and Presidentident and CEO of GN Netcom | ||
| Steen Laursen, VP Communication | ||
| Gitte Aabo, Chief Hearing | ||
| Gunther Pausch, Head RD | ||
| Aurangzeb Khan, VP Jabra | ||
| Ehtisham Rabbani, CEO SteelSeries | ||
| Lars AndersenLange, Head Affairs | ||
| Brian Pedersen, Chief Officer |
GGNDF Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is GN Store a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0875 | |||
| Return On Asset | 0.0376 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 5.06 B | |||
| Shares Outstanding | 127.97 M | |||
| Shares Owned By Institutions | 41.78 % | |||
| Price To Earning | 14.86 X | |||
| Price To Book | 2.91 X | |||
| Price To Sales | 0.17 X |
Currently Active Assets on Macroaxis
Other Information on Investing in GGNDF Pink Sheet
GN Store financial ratios help investors to determine whether GGNDF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GGNDF with respect to the benefits of owning GN Store security.